Cigna Group (CI) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Cigna Group (CI) stock forecast summary
On Oct. 16, 2026, CI is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5185 stocks scored that day.
Cigna Group is a large-cap company with a market capitalization of $79.88B. It ranks number 3 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast.
For CI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 27.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 28.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CI included.
Follow CI freeCI price chart and AI forecast
How CI ranks among 5185 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Cigna Group (CI) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
Valuation & Market
| Metric | CI | Rank |
|---|---|---|
| Market Cap | $79.88B | 3/10 |
| P/E Ratio | 12.51x | 7/7 |
| P/B Ratio | 1.87x | 9/10 |
| Dividend Yield | 2.03% | – |
| EPS | $24.17 | – |
| Book Value/Share | $161.29 | – |
| Revenue/Share | $1068.66 | – |
Profitability & Margins
| Metric | CI | Rank |
|---|---|---|
| ROE | 15.1% | 2/8 |
| ROA | 4.1% | 3/8 |
| ROIC | 9.8% | 3/10 |
| Gross Margin | 20.6% | 4/6 |
| Operating Margin | 3.5% | 3/10 |
| Net Margin | 2.3% | 4/8 |
| EBT Margin | 3.1% | 3/10 |
| Tax Rate | 19.2% | – |
Financial Health
| Metric | CI | Rank |
|---|---|---|
| Current Ratio | 0.85x | 9/10 |
| Quick Ratio | 0.74x | – |
| D/E Ratio | 2.68x | 4/10 |
| Financial Leverage | 3.69x | 4/10 |
| Interest Coverage | 7.5x | 5/9 |
| Working Capital | -$8.57B | 9/10 |
Cash Flow
| Metric | CI | Rank |
|---|---|---|
| Operating Cash Flow | $10.28B | 2/10 |
| OCF Growth YoY | 94.2% | 4/9 |
Operational Efficiency
| Metric | CI | Rank |
|---|---|---|
| Asset Turnover | 1.80x | 6/10 |
| Receivables Turnover | 9.2x | 6/6 |
| Inventory Turnover | 38.3x | – |
| Fixed Assets Turnover | 75.6x | 5/10 |
| Days Sales Outstanding | 40 days | 1/6 |
| Days Inventory | 10 days | – |
| Payables Period | 17 days | – |
| Cash Conversion Cycle | 32 days | – |
Income Statement
| Metric | CI | Rank |
|---|---|---|
| Total Revenue | $282.38B | 2/10 |
| Operating Income | $9.96B | 2/10 |
| Net Income | $6.42B | 2/8 |
| SG&A Expense | $14.16B | 4/8 |
| Cost of Goods Sold | $224.13B | 1/6 |
Dividend & Shareholder Information
| Metric | CI | Rank |
|---|---|---|
| Dividends Per Share | $6.15 | – |
| Payout Ratio | 25.4% | – |
| Shares Outstanding | 264M | – |
| Net Income Growth | 27.9% | 2/7 |
| EPS Growth | 32.8% | 2/7 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $46.99B | 29.9% of assets |
| Cash & Short-term Investments | $6.30B | 4.0% of assets |
| Accounts Receivable | $30.80B | 19.6% of assets |
| Inventory | $5.85B | 3.7% of assets |
| Total Liabilities | $114.17B | 72.7% of assets |
| Short-term Debt | $45.15B | 28.7% of assets |
CI quarterly financials and insider trading
Cigna Group (CI) industry peers
Companies classified under the same SEC industry code as Cigna Group (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CI Cigna Group | ▶ | $79.88B |
| UNH Unitedhealth Group Inc | ▲ | $360.32B |
| ELV Elevance Health, Inc. | ▶ | $92.88B |
| HUM Humana Inc | ▲ | $49.70B |
| CNC Centene Corp | ▶ | $34.16B |
| MOH Molina Healthcare, Inc. | ▲ | $10.82B |
| OSCR Oscar Health, Inc. | ▲ | $9.84B |
| CLOV Clover Health Investments, Corp. /De | ▲ | $2.38B |
| ALHC Alignment Healthcare, Inc. | ▲ | $1.72B |
| TRUP Trupanion, Inc. | ▼ | $1.23B |
Where CI sits on the market map
Cigna Group (CI) stock news
Loading...
Cigna Group (CI) stock forecast FAQ
What is the Cigna Group (CI) stock forecast?
On Oct. 16, 2026, CI is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5185 stocks scored that day.
How accurate are Cigna Group stock predictions?
For CI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 27.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 28.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Cigna Group forecasts updated?
Cigna Group forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Cigna Group's industry peers?
10 issuers in our coverage, CI included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.